Effects of antipsychotics on rumination in patients with first-episode psychosis.


Journal

Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617

Informations de publication

Date de publication:
20 12 2020
Historique:
received: 06 04 2020
revised: 21 05 2020
accepted: 22 05 2020
pubmed: 29 5 2020
medline: 28 8 2021
entrez: 29 5 2020
Statut: ppublish

Résumé

Rumination is a well-known risk factor for depression. It is also associated with negative and positive symptoms and suicidality in patients suffering from psychosis. However, no studies have addressed the effect of antipsychotics on rumination. Using the Brooding Scale (BS), we investigated the effect of antipsychotics on rumination at the 6-month follow up in patients with first-episode psychosis (n = 257). The relationship between rumination and other clinical variables was explored by conducting a correlation analysis and structural equation modeling (SEM). The clinical characteristics and short-term outcomes were compared between high and low ruminators at 6 months. Significant reductions in rumination and various clinical variables were observed at the 6-month follow-up. A significant correlation was observed between rumination and the score on the positive subscale of the Positive and Negative Syndrome Scale (PANSS). A direct path between the PANSS score and rumination was identified by SEM. High ruminators had more severe psychopathology, experienced more childhood traumas, and took less exercise than low ruminators. The recovery rate at 6 months was higher in low ruminators than in high ruminators. Our findings suggest that antipsychotics are beneficial for reducing rumination in patients with first-episode psychosis. The outcomes at the 6-month follow-up were better in low ruminators than high ruminators.

Sections du résumé

BACKGROUND
Rumination is a well-known risk factor for depression. It is also associated with negative and positive symptoms and suicidality in patients suffering from psychosis. However, no studies have addressed the effect of antipsychotics on rumination.
METHODS
Using the Brooding Scale (BS), we investigated the effect of antipsychotics on rumination at the 6-month follow up in patients with first-episode psychosis (n = 257). The relationship between rumination and other clinical variables was explored by conducting a correlation analysis and structural equation modeling (SEM). The clinical characteristics and short-term outcomes were compared between high and low ruminators at 6 months.
RESULTS
Significant reductions in rumination and various clinical variables were observed at the 6-month follow-up. A significant correlation was observed between rumination and the score on the positive subscale of the Positive and Negative Syndrome Scale (PANSS). A direct path between the PANSS score and rumination was identified by SEM. High ruminators had more severe psychopathology, experienced more childhood traumas, and took less exercise than low ruminators. The recovery rate at 6 months was higher in low ruminators than in high ruminators.
CONCLUSIONS
Our findings suggest that antipsychotics are beneficial for reducing rumination in patients with first-episode psychosis. The outcomes at the 6-month follow-up were better in low ruminators than high ruminators.

Identifiants

pubmed: 32464239
pii: S0278-5846(20)30299-2
doi: 10.1016/j.pnpbp.2020.109983
pii:
doi:

Substances chimiques

Antipsychotic Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109983

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest There are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.

Auteurs

Youngmin Lee (Y)

Department of Psychiatry, Jeonbuk National University Medical School, Jeonju, Republic of Korea.

Nam-In Kang (NI)

Department of psychiatry, Maeumsarang Hospital, Wanju, Jeollabuk-do, Republic of Korea.

Keon-Hak Lee (KH)

Department of psychiatry, Maeumsarang Hospital, Wanju, Jeollabuk-do, Republic of Korea.

YanHong Piao (Y)

Department of Psychiatry, Jeonbuk National University Medical School, Jeonju, Republic of Korea.

Yin Cui (Y)

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, PR China.

Sung-Wan Kim (SW)

Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea.

Bong Ju Lee (BJ)

Department of Psychiatry, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.

Jung Jin Kim (JJ)

Department of Psychiatry, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Republic of Korea.

Je-Chun Yu (JC)

Department of Psychiatry, Eulji University School of Medicine, Eulji University Hospital, Daejeon, Republic of Korea.

Kyu Young Lee (KY)

Department of Psychiatry, Eulji University School of Medicine, Eulji General Hospital, Seoul, Republic of Korea.

Seung-Hee Won (SH)

Department of Psychiatry, Kyungpook National University School of Medicine, Daegu, Republic of Korea.

Seung-Hwan Lee (SH)

Department of Psychiatry, Inje University College of Medicine, Goyang, Republic of Korea.

Seung-Hyun Kim (SH)

Department of Psychiatry, Korea University College of Medicine, Guro Hospital, Seoul, Republic of Korea.

Shi Hyun Kang (SH)

Department of Social Psychiatry and Rehabilitation, National Center for Mental Health, Seoul, Republic of Korea.

Euitae Kim (E)

Department of Psychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.

Saebom Kim (S)

Department of Social Welfare, Jeonbuk National University, Republic of Korea.

Young-Chul Chung (YC)

Department of Psychiatry, Jeonbuk National University Medical School, Jeonju, Republic of Korea; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju 561-756, Republic of Korea. Electronic address: chungyc@jbnu.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH